Nicholas Company, Inc. Astrazeneca PLC Call Options Transaction History
Nicholas Company, Inc.
- $5.66 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,465Shares Held
502MCall Options Held
7.13MPut Options Held
2.67M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.63 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.55 Billion2.42% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$3.06 Billion0.45% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.78 Billion0.16% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.23 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $276B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...